Inventor
Heidi Lopez de Diego
Inventor
Naerum, DK
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes18%
Y02PClimate change mitigation technologies in the production or processing of goods8%
Y10TTechnical subjects covered by former us classification8%
C07BGeneral methods of organic chemistry6%
C07CAcyclic or carbocyclic compounds4%
C07HSugars2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
10,857,149Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine202010,287,261Vortioxetine pyroglutamate201910,071,963Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease20189,938,286Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption20189,725,458'Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption'20179,227,946'1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment'20169,125,908'1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'20159,125,909'1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'20158,969,355'1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment'20158,598,348'Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine'20138,227,607'Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof'20128,076,320'Crystalline forms of a pharmaceutical compound'20117,648,991'Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2016Patents assigned to LUNDBECK & CO AS H (7)· patent assignee history
2010–2018Based in Nærum, DK· patent location history
2011–2013Patents assigned to DE DIEGO HEIDI LOPEZ (3)· patent assignee history
2011–2012Patents assigned to HOWELLS MARK (2)· patent assignee history
2011–2012Patents assigned to NIELSEN OLE (2)· patent assignee history
2011–2020Based in Naerum, DK· patent location history
2017–2020Patents assigned to H LUNDBECK AS (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LUNDBECK & CO AS H | 7 | 2010–2016 |
| H LUNDBECK AS | 5 | 2017–2020 |
| DE DIEGO HEIDI LOPEZself | 3 | 2011–2013 |
| HOWELLS MARK | 2 | 2011–2012 |
| NIELSEN OLE | 2 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Naerum, DK | 8 | 2011–2020 |
| Nærum, DK | 5 | 2010–2018 |